IRIS
CALZETTA, Luigino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.344
AS - Asia 10.291
EU - Europa 4.255
SA - Sud America 2.413
AF - Africa 645
Continente sconosciuto - Info sul continente non disponibili 506
OC - Oceania 23
Totale 28.477
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.999
SG - Singapore 4.577
VN - Vietnam 1.954
BR - Brasile 1.778
CN - Cina 1.251
IE - Irlanda 1.095
HK - Hong Kong 981
IT - Italia 778
BD - Bangladesh 518
SE - Svezia 490
ZA - Sudafrica 449
FR - Francia 370
NL - Olanda 370
DE - Germania 277
AR - Argentina 217
IN - India 210
RU - Federazione Russa 171
FI - Finlandia 169
GB - Regno Unito 146
CA - Canada 117
ID - Indonesia 113
CO - Colombia 106
MX - Messico 105
AT - Austria 98
EC - Ecuador 93
IQ - Iraq 88
VE - Venezuela 75
TR - Turchia 69
PK - Pakistan 65
CL - Cile 49
JP - Giappone 49
PH - Filippine 45
UA - Ucraina 44
EE - Estonia 39
PY - Paraguay 39
MA - Marocco 38
KR - Corea 37
UZ - Uzbekistan 37
SA - Arabia Saudita 34
TW - Taiwan 33
MY - Malesia 32
PL - Polonia 31
TH - Thailandia 31
ES - Italia 30
CI - Costa d'Avorio 27
BE - Belgio 25
PE - Perù 24
KE - Kenya 23
JM - Giamaica 22
TN - Tunisia 22
AE - Emirati Arabi Uniti 20
EG - Egitto 19
AZ - Azerbaigian 18
BO - Bolivia 17
IL - Israele 17
CR - Costa Rica 16
AU - Australia 15
ET - Etiopia 15
HN - Honduras 15
JO - Giordania 15
LT - Lituania 15
PT - Portogallo 15
UY - Uruguay 14
DZ - Algeria 13
DO - Repubblica Dominicana 12
KG - Kirghizistan 11
OM - Oman 11
AL - Albania 10
NI - Nicaragua 10
NP - Nepal 10
PS - Palestinian Territory 10
RS - Serbia 9
AM - Armenia 8
BG - Bulgaria 8
CH - Svizzera 8
GT - Guatemala 8
HU - Ungheria 8
IR - Iran 8
KZ - Kazakistan 7
LB - Libano 7
NZ - Nuova Zelanda 7
RO - Romania 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
BB - Barbados 6
HR - Croazia 6
PA - Panama 6
PR - Porto Rico 6
XK - ???statistics.table.value.countryCode.XK??? 6
BY - Bielorussia 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
GR - Grecia 4
KW - Kuwait 4
LU - Lussemburgo 4
LY - Libia 4
NG - Nigeria 4
SN - Senegal 4
AO - Angola 3
Totale 27.912
Salva come PNG Salva come JPEG
Città #
Singapore 2.133
San Jose 1.476
Chandler 1.267
Ashburn 1.171
Dublin 1.084
Hong Kong 941
Council Bluffs 613
Ho Chi Minh City 610
Santa Clara 590
Hanoi 443
Dallas 429
Johannesburg 417
Boardman 359
Lauterbourg 303
Beijing 288
Princeton 258
New York 159
Los Angeles 155
Helsinki 151
Des Moines 145
São Paulo 137
Munich 136
Milan 107
Rome 104
Wilmington 94
Haiphong 91
Moscow 84
Shanghai 81
Vienna 81
Da Nang 74
Columbus 65
Buffalo 64
Rio de Janeiro 61
Ann Arbor 59
Chicago 57
Parma 54
Phoenix 47
Naples 45
Tallinn 38
Hải Dương 37
Brasília 35
Brooklyn 34
Tashkent 34
Belo Horizonte 33
Marseille 33
Toronto 33
Atlanta 32
Biên Hòa 32
Frankfurt am Main 32
The Dalles 32
Curitiba 30
Dhaka 30
Guangzhou 30
Guayaquil 30
Bologna 29
Mexico City 29
Tianjin 29
Baghdad 28
Tokyo 28
Abidjan 27
Denver 27
London 27
Medellín 27
Quito 27
Nuremberg 26
Hefei 25
Jakarta 25
Brussels 24
Houston 24
Ninh Bình 24
Porto Alegre 24
Seattle 24
Warsaw 23
Bar Harbor 22
Salvador 22
Campinas 21
Caracas 21
Bogotá 20
Buenos Aires 20
Fortaleza 20
Goiânia 20
Montreal 20
Orem 20
Seoul 20
Bremen 19
Charlotte 19
Chennai 19
Fremont 19
Nairobi 19
Can Tho 18
Pune 18
Redmond 18
Baku 17
Philadelphia 17
Phủ Lý 17
Washington 17
Asunción 16
Shenzhen 16
Turin 16
Amman 15
Totale 15.961
Salva come PNG Salva come JPEG
Nome #
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 249
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea 225
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 207
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients 199
Small airways in asthma: from bench-to-bedside 196
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement 184
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD 183
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System 172
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 168
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom 166
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume 165
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients 161
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence 155
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system 155
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study 152
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines 151
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 149
Post-COVID-19 exaggerated exertional tachycardia: Relationship with pulmonary and cardiac sequelae 144
Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease 143
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 143
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 140
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis 139
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD 137
A 6MWT index to predict O-2 flow correcting exercise induced SpO(2) desaturation in ILD 134
Advances with glucocorticoids in the treatment of asthma: state of the art 131
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD 124
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review 124
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 123
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review 123
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination 123
Analysis of exhaled breath fingerprints and volatile organic compounds in COPD 123
Corrigendum to “Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat” [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342] (Pulmonary Pharmacology & Therapeutics (2025) 88, (S1094553924000580), (10.1016/j.pupt.2024.102342)) 119
A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD 118
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 117
A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ) 115
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study 115
Cardiovascular disease in copd 115
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD 114
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 114
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis 113
Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical review 110
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 110
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat 109
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: A comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine 109
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review 109
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 107
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 107
Comparative studies of dual bronchodilation in COPD 106
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 105
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 104
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma 104
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 104
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease 103
Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene 102
Challenges in treating patients with comorbid asthma and bronchiectasis 101
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania” 101
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update 100
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms 100
The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications 99
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study 99
The interplay between diabetes mellitus and chronic obstructive pulmonary disease. An overview 98
Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short 98
Beyond Dual Bronchodilation - Triple Therapy, When and Why 98
ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 98
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials 98
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 98
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma 97
Investigational anti IL-13 asthma treatments: a 2023 update 97
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem 97
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies 97
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 96
Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration 96
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement 94
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine 94
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 94
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab 93
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD 92
Asthma and comorbidities: recent advances 92
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? 92
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment 91
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application 89
Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging 89
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences 89
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 89
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? 88
SMART for the treatment of asthma: A network meta-analysis of real-world evidence 88
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 88
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 87
Onset of action of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in patients with COPD 87
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses 87
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review 87
Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways 86
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? 86
TSLP Inhibitors for Asthma: Current Status and Future Prospects 86
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review 86
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways 86
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients 86
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database 86
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile 85
Biologics for asthma and risk of pneumonia 85
Totale 11.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.105 0 0 0 20 76 39 257 75 46 3 37 552
2022/20233.941 509 313 229 258 277 455 48 276 1.378 28 134 36
2023/20241.415 100 161 56 65 141 259 103 82 63 99 102 184
2024/20255.424 49 330 454 273 543 512 210 238 762 563 339 1.151
2025/202613.902 951 1.286 1.816 1.474 1.949 483 1.338 496 1.972 1.044 598 495
2026/20272.378 507 749 994 128 0 0 0 0 0 0 0 0
Totale 28.477